title: [Long-term results of iridocyclectomy for iris tumours].
abstract: BACKGROUND
  The aim of this study was to evaluate the long-term survival rate and functional results after iridocyclectomy.
  
  
  METHODS
  Between 1980 and 2002 39 patients (26 female and 13 male) ranging in age from 20 to 79 years (median m = 58 years) underwent iridocyclectomy for a tumour of periphery iris by means of a lamellar technique or by trepanating. Follow-up time ranged from 3 months to 24 years (m = 11.2 years).
  
  
  RESULTS
  In 21 cases (54 %) there was a malignant tumour including 20 melanomas (mostly spindle-cell and mixed-cell melanomas) and one filiae of a bronchial carcinoma. There was a variety of histopathological entities in the 18 benign lesions (46 %). Naevi were the most frequent. The outcome was satisfactory: 57 % of the patients kept a visual acuity of > 0.5. Three eyes had to be enucleated. The rate of recurrence was 10 % (4 cases). The Kaplan-Meyer estimate for the 10-year-survival of the patients with a malignant iris tumour was 77 %. Two patients died of metastic melanoma following spindle-cell and mixed-cell melanoma.
  
  
  CONCLUSIONS
  The long-term functional results after Iridocyclectomy are good, whereas complications and recurrences are rare. The 10-year-survival is high. Over a long period iridocyclectomy is a recommendable surgical procedure for removal of progredient tumours of the anterior uvea.
authors.affiliation: Universitätsaugenklinik, Universität Münster.
authors.forename: D
authors.initials: D
authors.lastname: Daubner
authors.forename: V
authors.initials: V
authors.lastname: Prokosch
authors.forename: H
authors.initials: H
authors.lastname: Busse
authors.forename: T
authors.initials: T
authors.lastname: Stupp
mesh_terms: D000328:Adult; D000368:Aged; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D032801:Iridectomy / Q000401:mortality* / Q000706:statistics & numerical data; D015811:Iris Neoplasms / Q000401:mortality* / Q000601:surgery*; D008137:Longitudinal Studies; D008297:Male; D008875:Middle Aged; D015995:Prevalence; D016019:Survival Analysis; D015996:Survival Rate; D016896:Treatment Outcome